mRNA-based technology for engineered regenerative medicine
Authors:
- Xueyan ZhenXZXueyan Zhen
- Wei ChenWCWei Chen
- Wei TaoWTWei Tao
Open Access
- 26 August 2025
- journal article
- Published by Elsevier in Cell Biomaterials
- Vol. 2 (1)
Abstract
No abstract availableFunding Information
- American Lung Association (LCD1034625)
- American Heart Association (23TPA1072337)
- American Heart Association (23SCEFIA1151841)
- LEO Fondet (LF-OC-24-001665)
- U.S. Department of War (HT9425-25-1-0227)
- U.S. Department of War (HT9425-25-1-0683)
- American Society of Transplantation (1173492)
- Harvard University
- Novo Nordisk (2023A009607)
This publication has 148 references indexed in Scilit:
- Therapeutic nucleic acids in regenerative medicine and tissue repairNano Research, 2024
- Small Molecule‐Inducible and Photoactivatable Cellular RNA N1‐Methyladenosine EditingAngewandte Chemie International Edition, 2024
- Nano-bio interactions in mRNA nanomedicine: Challenges and opportunities for targeted mRNA deliveryAdvanced Drug Delivery Reviews, 2023
- Lymphatic vessels in bone support regeneration after injuryCell, 2023
- Humoral and cellular immune memory to four COVID-19 vaccinesCell, 2022
- Programmed BMP-2 release from biphasic calcium phosphates for optimal bone regenerationBiomaterials, 2021
- Chimeric contribution of human extended pluripotent stem cells to monkey embryos ex vivoCell, 2021
- Chemo‐Enzymatic Modification of the 5′ Cap Maintains Translation and Increases Immunogenic Properties of mRNAAngewandte Chemie International Edition, 2021
- A Systematic Study of Unsaturation in Lipid Nanoparticles Leads to Improved mRNA Transfection In VivoAngewandte Chemie International Edition, 2021
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006